PharmaMax Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.48M
Latest Deal Amount
  • Investors
  • 7

PharmaMax General Information

Description

Developer of allergy relief products for chronic and acute nasal irritations. The company manufactures antimicrobial nasal sprays, gels and anti-allergen masks designed to treat allergic and rhinitis conditions, aiming to provide high-quality oral and nasal medicines for patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • No.1, Nanbatang Road
  • China Medical City
  • Taizhou, Jiangsu
  • China
+86 0523 0000 0000

PharmaMax Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaMax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 18-Feb-2019 $1.48M 00.000 00000 Completed Generating Revenue
3. Later Stage VC 17-Apr-2018 Completed Generating Revenue
2. Later Stage VC 30-Sep-2016 Completed Generating Revenue
1. Early Stage VC (Series A) 15-May-2014 Completed Generating Revenue
To view PharmaMax’s complete valuation and funding history, request access »

PharmaMax Executive Team (3)

Name Title Board Seat Contact Info
Zhijun Jiang Ph.D Co-Founder & Chief Executive Officer
Albert Yeung Independent Director
To view PharmaMax’s complete executive team members history, request access »

PharmaMax Board Members (2)

Name Representing Role Since
David Zezza Pacific Advantage Capital Board Member 000 0000
To view PharmaMax’s complete board members history, request access »

PharmaMax Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
PharmaMax USA Corporation Majority 000 0000 000000 0
Efung Capital Venture Capital Minority 000 0000 000000 0
Hongshi Capital Venture Capital Minority 000 0000 000000 0
Nuoyuan Capital Other Minority 000 0000 000000 0
Pacific Advantage Capital PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »